AN1 ASX Chart
Snapshot
Anagenics Limited (AN1, formerly Cellmid Limited) is a health and beauty-tech business growing through the global distribution and sales of its proprietary and licensed brands of differentiated, clinically validated anti-aging solutions. BLC Cosmetics Pty Ltd is Anagenics' wholly owned subsidiary focused on sales and distribution of Australian and international brands of cosmetic and wellness products. Advangen Pty Ltd is Anagenics' wholly owned subsidiary engaged in the development and sale of proprietary products for hair, skin and body.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -82.26% |
Announcements
Corporate Overview
Corporate Details
Head Office | Sydney NSW 2000 |
Website | www.anagenics.com |
Registry | Automic Group |
Auditor | Pitcher Partners |
Date Listed | 9 Dec 2005 |
Upcoming Calendar (Forecasted)
No calendar entries available.
Former Company Names
- Cellmid Limited (CDY ), 14/12/2021
- Medical Therapies Limited (MTY) on 19/11/2009
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
AN1 directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of AN1 directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Dennis Keith Eck | 31/08/2023 | 19,196,581 | 5.25 |
HGL Limited | 15/02/2024 | 175,444,690 | 41.86 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
15-02-24 | HGL Limited | 2,150,000 | 45.75 | 41.86 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.008 | 28 June |
2023 | $0.017 | 30 June |
2022 | $0.023 | 30 June |
2021 | $0.06 | 30 June |
2020 | $0.10 | 30 June |
2019 | $0.175 | 28 June |
2018 | $0.47 | 29 June |
2017 | $0.025 | 30 June |
2016 | $0.033 | 30 June |
2015 | $0.03 | 30 June |
2014 | $0.026 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.